Human Growth Hormone Drugs Market Report

Global and Region Human Growth Hormone Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：192
  • REPORT CODE：GMM920782
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • HGH, produced by the pituitary gland, spurs growth in children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function. Produced synthetically, HGH is the active ingredient in a number of prescription drugs and in other products available widely over the Internet.

    Human growth hormone is a peptide hormone, stimulating growth in children and adolescents, and is produced by the pituitary gland. It helps in the growth of bones and muscles by specific cellular differentiation. Apart from stimulating growth, the human growth hormone also regulates carbohydrate metabolism, protein metabolism and fat metabolism. Moreover, the usage of human growth hormone drugs in growth hormone deficient patient has shown significant positive results on the patient’s working capacity, mental alertness and memory. The over secretion of growth hormone leads to gigantism and its deficiency causes dwarfism. The human growth hormone drugs are developed and manufactured by recombinant DNA technology. Earlier, these drugs were mostly used as replacement therapy in pediatric and adult patients, having the deficiency of growth hormones. However, the technological advancements and increased research and development in growth hormone drugs, have resulted in the development of anti-aging drugs and performance enhancers.

    The report details the trend, potential and market size of Human Growth Hormone Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Human Growth Hormone Drugsmarket, defines the market attractiveness level of Human Growth Hormone Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Human Growth Hormone Drugs industry, describes the types of Human Growth Hormone Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Growth Hormone Drugs market and the development prospects and opportunities of Human Growth Hormone Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Growth Hormone Drugs market in Chapter 13.

    By Player:

    • Eli Lilly and Company (US)

    • Pfizer, Inc (US)

    • Genentech, Inc (US)

    • Ferring Holding SA (Switzerland)

    • GeneScience Pharmaceuticals Co, Ltd (China)

    • Novo Nordisk A/S (Denmark)

    • Sandoz International GmbH (Germany)

    • Merck KgaA (Germany)

    By Type:

    • Norditropin

    • Genotropin

    • Humatrope

    • Saizen

    • Omnitrope

    • Somatropin Biopartners

    By End-User:

    • Prader-Willi Syndrome

    • Turner Syndrome

    • Short Stature Homeobox Gene

    • Small for Gestational Age

    • Chronic Renal Insufficiency

    • Short Bowel Syndrome

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Human Growth Hormone Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Human Growth Hormone Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Human Growth Hormone Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Human Growth Hormone Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Human Growth Hormone Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Human Growth Hormone Drugs Consumption (2017-2022)

    • 7.2 United States Human Growth Hormone Drugs Consumption (2017-2022)

    • 7.3 Europe Human Growth Hormone Drugs Consumption (2017-2022)

    • 7.4 China Human Growth Hormone Drugs Consumption (2017-2022)

    • 7.5 Japan Human Growth Hormone Drugs Consumption (2017-2022)

    • 7.6 India Human Growth Hormone Drugs Consumption (2017-2022)

    • 7.7 South Korea Human Growth Hormone Drugs Consumption (2017-2022)

    8 Region and Country-wise Human Growth Hormone Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Human Growth Hormone Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Human Growth Hormone Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Human Growth Hormone Drugs Consumption Forecast (2022-2028)

    • 8.4 China Human Growth Hormone Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Human Growth Hormone Drugs Consumption Forecast (2022-2028)

    • 8.6 India Human Growth Hormone Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Human Growth Hormone Drugs Consumption Forecast (2022-2028)

    9 Global Human Growth Hormone Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Human Growth Hormone Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Norditropin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Genotropin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Humatrope Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Saizen Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Omnitrope Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Somatropin Biopartners Consumption and Growth Rate (2017-2022)

    • 9.2 Global Human Growth Hormone Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Prader-Willi Syndrome Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Turner Syndrome Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Short Stature Homeobox Gene Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Small for Gestational Age Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Chronic Renal Insufficiency Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Short Bowel Syndrome Consumption and Growth Rate (2017-2022)

    10 Global Human Growth Hormone Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Human Growth Hormone Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Norditropin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Genotropin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Humatrope Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Saizen Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Omnitrope Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Somatropin Biopartners Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Human Growth Hormone Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Prader-Willi Syndrome Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Turner Syndrome Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Short Stature Homeobox Gene Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Small for Gestational Age Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Chronic Renal Insufficiency Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)

    11 Global Human Growth Hormone Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Human Growth Hormone Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Human Growth Hormone Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Human Growth Hormone Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Human Growth Hormone Drugs Market Competitive Analysis

    • 14.1 Eli Lilly and Company (US)

      • 14.1.1 Eli Lilly and Company (US) Company Details

      • 14.1.2 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Product and Service

    • 14.2 Pfizer, Inc (US)

      • 14.2.1 Pfizer, Inc (US) Company Details

      • 14.2.2 Pfizer, Inc (US) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer, Inc (US) Human Growth Hormone Drugs Product and Service

    • 14.3 Genentech, Inc (US)

      • 14.3.1 Genentech, Inc (US) Company Details

      • 14.3.2 Genentech, Inc (US) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Genentech, Inc (US) Human Growth Hormone Drugs Product and Service

    • 14.4 Ferring Holding SA (Switzerland)

      • 14.4.1 Ferring Holding SA (Switzerland) Company Details

      • 14.4.2 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product and Service

    • 14.5 GeneScience Pharmaceuticals Co, Ltd (China)

      • 14.5.1 GeneScience Pharmaceuticals Co, Ltd (China) Company Details

      • 14.5.2 GeneScience Pharmaceuticals Co, Ltd (China) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GeneScience Pharmaceuticals Co, Ltd (China) Human Growth Hormone Drugs Product and Service

    • 14.6 Novo Nordisk A/S (Denmark)

      • 14.6.1 Novo Nordisk A/S (Denmark) Company Details

      • 14.6.2 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product and Service

    • 14.7 Sandoz International GmbH (Germany)

      • 14.7.1 Sandoz International GmbH (Germany) Company Details

      • 14.7.2 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product and Service

    • 14.8 Merck KgaA (Germany)

      • 14.8.1 Merck KgaA (Germany) Company Details

      • 14.8.2 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Merck KgaA (Germany) Human Growth Hormone Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Human Growth Hormone Drugs

    • Figure Human Growth Hormone Drugs Picture

    • Table Global Human Growth Hormone Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human Growth Hormone Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human Growth Hormone Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Human Growth Hormone Drugs Consumption by Country (2017-2022)

    • Figure United States Human Growth Hormone Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Human Growth Hormone Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Human Growth Hormone Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Human Growth Hormone Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Human Growth Hormone Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Human Growth Hormone Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Human Growth Hormone Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Human Growth Hormone Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Human Growth Hormone Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Human Growth Hormone Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Human Growth Hormone Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Human Growth Hormone Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Human Growth Hormone Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Norditropin Consumption and Growth Rate (2017-2022)

    • Figure Global Genotropin Consumption and Growth Rate (2017-2022)

    • Figure Global Humatrope Consumption and Growth Rate (2017-2022)

    • Figure Global Saizen Consumption and Growth Rate (2017-2022)

    • Figure Global Omnitrope Consumption and Growth Rate (2017-2022)

    • Figure Global Somatropin Biopartners Consumption and Growth Rate (2017-2022)

    • Figure Global Prader-Willi Syndrome Consumption and Growth Rate (2017-2022)

    • Figure Global Turner Syndrome Consumption and Growth Rate (2017-2022)

    • Figure Global Short Stature Homeobox Gene Consumption and Growth Rate (2017-2022)

    • Figure Global Small for Gestational Age Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Renal Insufficiency Consumption and Growth Rate (2017-2022)

    • Figure Global Short Bowel Syndrome Consumption and Growth Rate (2017-2022)

    • Figure Global Norditropin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genotropin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Humatrope Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Saizen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Omnitrope Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Somatropin Biopartners Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prader-Willi Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Turner Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Short Stature Homeobox Gene Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Small for Gestational Age Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Renal Insufficiency Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Short Bowel Syndrome Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Human Growth Hormone Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Human Growth Hormone Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Eli Lilly and Company (US) (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company (US) Human Growth Hormone Drugs Product and Service

    • Table Pfizer, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Pfizer, Inc (US) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer, Inc (US) Human Growth Hormone Drugs Product and Service

    • Table Genentech, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Genentech, Inc (US) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech, Inc (US) Human Growth Hormone Drugs Product and Service

    • Table Ferring Holding SA (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product and Service

    • Table GeneScience Pharmaceuticals Co, Ltd (China) (Foundation Year, Company Profile and etc.)

    • Table GeneScience Pharmaceuticals Co, Ltd (China) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GeneScience Pharmaceuticals Co, Ltd (China) Human Growth Hormone Drugs Product and Service

    • Table Novo Nordisk A/S (Denmark) (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product and Service

    • Table Sandoz International GmbH (Germany) (Foundation Year, Company Profile and etc.)

    • Table Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product and Service

    • Table Merck KgaA (Germany) (Foundation Year, Company Profile and etc.)

    • Table Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KgaA (Germany) Human Growth Hormone Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US